Solventum Balance Sheet Health
Financial Health criteria checks 1/6
Solventum has a total shareholder equity of $3.6B and total debt of $7.8B, which brings its debt-to-equity ratio to 214.4%. Its total assets and total liabilities are $15.1B and $11.4B respectively. Solventum's EBIT is $843.0M making its interest coverage ratio 2. It has cash and short-term investments of $492.0M.
Key information
214.40%
Debt to equity ratio
US$7.82b
Debt
| Interest coverage ratio | 2x |
| Cash | US$492.00m |
| Equity | US$3.65b |
| Total liabilities | US$11.43b |
| Total assets | US$15.07b |
Recent financial health updates
Recent updates
Solventum: A Solid Performance Here
Oct 22Solventum's (NYSE:SOLV) Shareholders Have More To Worry About Than Only Soft Earnings
May 16
Solventum Corporation Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year
May 11
New VAC Product And AI Will Simplify Procedures
Streamlining operations and divesting non-core assets are expected to improve margins, reduce leverage, and focus growth efforts on core segments.Solventum: An Impressive Sale Of Purification And Filtration
Feb 26Solventum Corporation's (NYSE:SOLV) Intrinsic Value Is Potentially 32% Above Its Share Price
Feb 02These 4 Measures Indicate That Solventum (NYSE:SOLV) Is Using Debt Extensively
Dec 11Solventum: Concerns After A Partial Re-Rating
Nov 30Solventum: No Rush To Buy As Post-Spin Execution Will Take Time To Play Out
Sep 11Solventum: Stumbling Out Of The Gate
Jul 07Solventum: A Reasonable Start, Still Some Questions To Be Asked
May 173M Says Bye To Solventum - Why I Stick To My Bullish Call
Apr 02Financial Position Analysis
Short Term Liabilities: SOLV's short term assets ($3.2B) exceed its short term liabilities ($2.6B).
Long Term Liabilities: SOLV's short term assets ($3.2B) do not cover its long term liabilities ($8.8B).
Debt to Equity History and Analysis
Debt Level: SOLV's net debt to equity ratio (200.9%) is considered high.
Reducing Debt: Insufficient data to determine if SOLV's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: SOLV's debt is not well covered by operating cash flow (7.5%).
Interest Coverage: SOLV's interest payments on its debt are not well covered by EBIT (2x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/03 11:19 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Solventum Corporation is covered by 15 analysts. 11 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Travis Steed | BofA Global Research |
| Travis Steed | BofA Global Research |
| Michael Gorman | BTIG |